Mark Anthony McCamish, Director at AVADEL PHARMACEUTICALS PLC (AVDL), bought 342,000 shares at $5.83 ($2.0M) on 2020-09-17, disclosed to the SEC on 2020-09-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.73 | 118,602 | $680K | 34.5% |
| 2 | $5.73 | 118,602 | $680K | 34.5% |
| 3 | $5.83 | 52,398 | $305K | 15.5% |
| 4 | $5.83 | 52,398 | $305K | 15.5% |
| Total | $5.76 avg | 342,000 | $2.0M | 100% |
| Filing → |
| FTSV | SELL | 2020-04-03 | $6.2M | — | Filing → |
| FTSV | SELL | 2019-06-27 | $181K | — | Filing → |
| FTSV | SELL | 2019-06-24 | $183K | — | Filing → |